Singapore, Singapore

Zi Zong Ho

This inventor holds 1 USPTO granted patent. Top assignee: Lion Tcr Pte. Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zi Zong Ho. Retrieved from https://idiyas.com/inventor/zi-zong-ho

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Zi Zong Ho

Introduction

Zi Zong Ho is a prominent inventor based in Singapore, known for his significant contributions to the field of personalized medicine. He has developed innovative solutions that aim to improve healthcare outcomes for patients. His work is particularly focused on the development of specific T-cell receptors that can target hepatitis B virus (HBV).

Latest Patents

Zi Zong Ho holds a patent titled "HBV Specific TCR Library and Its Use as Personalized Medicine." This patent represents a breakthrough in the treatment of HBV, showcasing his commitment to advancing medical science through innovative approaches.

Career Highlights

Zi Zong Ho is currently employed at Lion TCR Pte. Ltd., where he continues to push the boundaries of research and development in immunotherapy. His work at the company has positioned him as a key player in the field of personalized medicine.

Collaborations

Throughout his career, Zi Zong Ho has collaborated with notable colleagues, including Lu-En Wai and Antonio Bertoletti. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Zi Zong Ho's contributions to the field of personalized medicine through his innovative patent and collaborative efforts highlight his dedication to improving healthcare. His work continues to inspire advancements in medical research and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…